19.01.2017 • News

Azelis Americas Buys Ross Organic

Frank Bergonzi, CEO and president of Azelis Americas, said one of the pillars...
Frank Bergonzi, CEO and president of Azelis Americas, said one of the pillars of its personal care strategy has been to focus on increasing its footprint in the US. He commented: “This acquisition affords us the extended reach and history of sustainable organic growth in a strategically important market segment.”

Azelis Americas has acquired Ross Organic, a specialty chemicals distributor located in Santa Fe, California, USA. Financial details were not disclosed. The move, said Azelis Americas, strengthens its presence in the specialty growth markets in the western US. Ross Organic sells into the personal care and home care/industrial cleaning markets.

Frank Bergonzi, CEO and president of Azelis Americas, said one of the pillars of its personal care strategy has been to focus on increasing its footprint in the US. He commented: “This acquisition affords us the extended reach and history of sustainable organic growth in a strategically important market segment.” The DeWolf acquisition in February 2014 has been “a resounding success,” Bergonzi said, while adding he believes Ross Organic will provide a similar boost in the market.

Stephanie Ross Leshney, co-owner and president of Ross Organic, said the deal will further strengthen its customer and supplier capabilities as well as ensure it remains the preeminent personal distributor in the western states.

Azelis Americas said it does not plan to make any significant changes to Ross Organic’s team and capabilities. The Connecticut-based company was formerly known as Koda Distribution Group before being acquired by Europe’s Azelis Group in December 2015.

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read